Search the Newsreel

Geron Corporation - Common Stock (NQ: GERN)

This page provides recent news headlines and financial updates for Geron Corporation (NASDAQ: GERN). Key topics include Q2 2026 earnings, RYTELO sales performance, and upcoming earnings schedules, along with stock price movements and analyst assessments. The company's RYTELO demand grew, though recent earnings reports …

What's Going On With Volatus Aerospace Inc. Stock Thursday?

Omeros outlines Q3 2026 interest expense of about $6.5M while advancing $287,000 NTAP for YARTEMLEA

Earnings Call Insights: Omeros Corporation (OMER) Q2 2026 MANAGEMENT VIEW * "YARTEMLEA generated $32.2 million in gross sales in its first full quarter on the market," "operations generated $4.1 million of positive cash flow during the quarter," and "we meaningfully strengthened our capital structure …

Firefly CEO Jason Kim Sees ‘So Much Demand’ For Rocket Launches As Capacity Hits Record Constraints

Firefly Aerospace CEO Jason Kim states that demand for rocket launches is at an unprecedented high, with existing and new customers showing strong interest. The company recently extended its agreement with Lockheed Martin for up to 25 launches through 2031 and is ramping up …

Spero Therapeutics Inc (SPRO) (Q2 2026) Earnings Call Highlights: FDA Approval of Utebzi and ...

This article first appeared on GuruFocus. Cash and Cash Equivalents: $50.8 million as of June 30, 2026, excluding net proceeds from the July 2026 royalty financing. Revenue: No revenue for Q2 2026, compared to $14.2 million in Q2 2025, primarily due to prior collaboration …

Firefly Aerospace (FLY) Is Up 16.2% After Record Q2 Sales And New Lockheed Launch Deal - Has The Bull Case Changed?

In the second quarter of 2026, Firefly Aerospace reported record sales of US$117.68 million but widened its net loss to US$92.32 million, alongside a two-year extension of its multi-launch agreement with Lockheed Martin for up to 25 Alpha Block II rocket missions through 2031 …

Continental Aerospace Warns of Deeper First-Half Loss Amid Property Disposal Hit

Ero Copper (ERO) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 11:30 a.m. ET CALL PARTICIPANTS VP, Investor Relations - Farooq HamedPresident and Chief Executive Officer - Makko DeFilippoExecutive Vice President and Chief Financial Officer - Wayne DrierExecutive Vice President and Chief Operating Officer …

StandardAero CEO Russell Ford sells $1,230 in stock By Investing.com

StandardAero CEO Russell Ford sold 41 shares of common stock for $1,230 on August 10, 2026, as part of a Rule 10b5-1 trading plan. Following the sale, he directly holds 14,342 shares and indirectly owns 295,532 shares through a Family LLC. The company's stock …

Spero outlines cash runway into the second half of 2029 following $105M royalty financing

Earnings Call Insights: Spero Therapeutics (SPRO) Q2 2026 MANAGEMENT VIEW * "In the last 90 days, we had 4 major milestones. The FDA approved Utebzi... We in-licensed SP001 and repositioned the company's pipeline to focus on immune-mediated diseases. We closed $105 million nondilutive, nonrecourse …

Telix Pharmaceuticals (ASX:TLX) Posts US$247M Quarter and Targets Over US$1B 2026 Revenue Plus Other Income

Telix Pharmaceuticals reported its strongest quarterly revenue to date, reaching US$247 million in Q2 2026, driven by its Precision Medicine division. The company projects its total 2026 revenue plus other income to exceed US$1 billion, bolstered by a US$40 million payment from a new …

Howmet Aerospace (HWM) Q1 2026 Earnings Call Transcript

Valero Energy (VLO) Is Up 9.2% After Robust Q2 Earnings And US$8.4 Billion Buyback Completion

In the second quarter and first half of 2026, Valero Energy reported sharply higher sales and net income year over year, while completing a large share repurchase program totaling 48,114,319 shares for about US$8.42 billion. This combination of strong earnings and substantial buybacks materially …

Omeros (NASDAQ:OMER) Releases Earnings Results, Beats Estimates By $0.29 EPS

StandardAero CEO Russell Ford sells $1,230 in stock

StandardAero CEO Russell Ford sold 41 shares of common stock for $1,230 on August 10, 2026, under a pre-arranged trading plan. Despite the sale, he retains significant direct and indirect holdings in the company, which recently reported a 4.6% revenue increase and raised its …

Spero Therapeutics 2Q 2026: Revenue $0M, EPS $(0.16) — 10-Q Summary

Spero Therapeutics reported its second quarter 2026 results, showing $0M in revenue and a diluted EPS of $(0.16), a significant decrease from the prior year. Key business updates include the FDA approval of Utebzi, the in-license and development of SP001, and a $105M non-dilutive …

With EPS Growth And More, A-Sonic Aerospace (SGX:BTJ) Makes An Interesting Case

Is Vertical Aerospace (EVTL) Using Complex New Financing To Clarify Or Cloud Its Path To Certification?

Is Howmet Aerospace (HWM) Expensive Following Raised 2026 Guidance?

AeroVironment (AVAV) Stock Declines While Market Improves: Some Information for Investors

AeroVironment (AVAV) closed at $193.81 in the latest trading session, marking a -1.13% move from the prior day. The stock trailed the S&P 500, which registered a daily gain of 0.26%. Meanwhile, the Dow lost 0.04%, and the Nasdaq, a tech-heavy index, added 0.54%. …

SPRO: FDA approval, immunology pivot, and $105M financing extend cash runway into 2029

Spero Therapeutics (SPRO) received FDA approval for Utebzi, allowing a strategic shift to immunology with the in-licensing of SP001 and $105 million in non-dilutive financing. This extends their cash runway into the second half of 2029, with a Phase II trial for SP001 in …

Firefly Aerospace Inc. Stock 12‑Month Price Target Cut to $38.6, Implies 46% Upside

Firefly Aerospace Inc.'s average 12-month price target has been reduced from $43.67 to $38.6 by analysts, based on estimates from 10 analysts. This new target implies a potential upside of approximately 46% from the August 11 closing price. Despite the cut, the consensus rating …

Longeveron LLC earnings missed by $0.01, revenue fell short of estimates

Honeywell Aerospace announces completion of exchange offer

PHOENIX, Aug. 12, 2026 /PRNewswire/ -- Honeywell Aerospace Inc. ("Honeywell Aerospace," Nasdaq: HONA) announced today the final results of its offer to exchange (the "Exchange Offer") certain of its outstanding unregistered notes for new registered notes.Honeywell Aerospace Logo Under the Exchange Offer, Honeywell Aerospace …

Earnings call transcript: Spero Therapeutics posts small q2 2026 EPS beat

This article first appeared on GuruFocus. Cash and Cash Equivalents: $50.8 million as of June 30, 2026, excluding net proceeds from the July 2026 royalty financing. Revenue: No revenue for Q2 2026, compared to $14.2 million in Q2 2025, primarily due to prior collaboration …

Omeros Corporation reports results for the quarter ended June 30 - Earnings Summary

Omeros Corporation has released its earnings summary for the quarter that ended on June 30. The article, sourced from Reuters, provides a concise overview of the company's financial performance during this period. Readers can access the full report for detailed insights into the results.

99.998% of Honeywell Aerospace's 2046 Notes Were Tendered

Honeywell Aerospace (Nasdaq: HONA) announced the completion of its exchange offer for $16 billion in senior notes, allowing holders to swap unregistered notes for registered ones. The offer, which expired on August 10, 2026, saw participation rates between 98.000% and 99.998% across nine series …

Earnings call transcript: Longeveron misses Q2 2026 estimates as cash runs tight

Earnings Flash (MAL.TO) Magellan Aerospace Corporation Reports Q2 Revenue C$305.6M, vs. FactSet Est of C$289.5M

Spero Therapeutics (NASDAQ:SPRO) Posts Earnings Results, Beats Expectations By $0.01 EPS

Omeros (OMER) Q2 Earnings and Revenues Beat Estimates

Insider Selling: Regeneron Pharmaceuticals (NASDAQ:REGN) Director Sells $640,000.00 in Stock

Regeneron Pharmaceuticals director Huda Zoghbi sold 800 shares of the company's stock for $640,000, reducing her direct ownership by nearly 32%. This transaction occurred under a pre-arranged Rule 10b5-1 trading plan. The sale comes as Regeneron reported strong quarterly earnings with revenue up 16.7% …

Magellan Aerospace Corporation Announces Financial Results

Omeros Corporation (NASDAQ: OMER) turns profitable as YARTEMLEA sales ramp

Omeros Corporation (NASDAQ: OMER) reported a significant return to profitability in Q2 2026, driven by $28.5 million in product sales from its newly launched drug YARTEMLEA. The company achieved a net income of $13.2 million for the quarter and $69.3 million for the first …

Omeros surges 13% on strong earnings and revenue beat

Omeros Corporation (NASDAQ:OMER) reported second-quarter results that significantly surpassed analyst expectations, driven by strong sales of its new TA-TMA treatment, YARTEMLEA. The company posted adjusted earnings per share of $0.02 and revenue of $28.5 million, significantly beating estimates. Shares of Omeros surged 13% in …

OMEROS ($OMER) Releases Q2 2026 Earnings, Stock Rises